In the near term, Avita Medical is focused on advancing the use of the RECELL system in treating trauma and soft tissue injuries such as lacerations and gun shot wounds. In September, it secured an Investigational Device Exemption (IDE) to pursue FDA approval for soft tissue reconstruction. The study will assess the safety and effectiveness of the RECELL System in a minimum of 65 trauma patients. Three sites are screening patients with the first patient expected shortly.